Drugs / 18F-Al-NOTA-MATBBN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03094897 | Apr 2017 → Dec 2020 | breast neoplasm, prostate neoplasm | Wuxi No. 4 People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-Al-NOTA-MATBBN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03094897 ↗ |
| Modality | Diagnostic / imaging agent | “18F-Al-NOTA-MATBBN(PET imaging agent)” NCT03094897 ↗ |
| Route | Intravenous | “18F-Al-NOTA-MATBBN(PET imaging agent) given by vein before PET scans.” NCT03094897 ↗ |